EFFECTIVENESS OF NESTING ON POSTURE AND MOTOR PERFORMANCE AMONG HIGH RISK NEWBORN

Background and objectives: Lixisenatide, a selective short-acting glucagon-like peptide 1?receptor agonist (GLP-1RAs), approved in many countries worldwidefor use with oral glucose-lowering agents with or without basal insulin for the treatment of adults with uncontrolled type 2 diabetes mellitus (T2DM) as an adjunct to diet and exercise. The aim of this study was to assess the effectiveness of basal insulin treatmentregimen intensification with Lixisenatide compared with another injectable drugin patients with T2DM. We also aimed to identify the respective predictive factors for glycemic control.